These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 3466241)
21. Legal and regulatory considerations in environmental biotechnology applications. McGarity TO Recomb DNA Tech Bull; 1985 Mar; 8(1):1-6. PubMed ID: 3858922 [No Abstract] [Full Text] [Related]
22. A primer on the requirements for select agents and toxins used in biomedical and agricultural research applications. Johnston TP Health Phys; 2006 May; 90(5 Suppl):S56-61. PubMed ID: 16607169 [TBL] [Abstract][Full Text] [Related]
23. Recombinant DNA: international guidelines. Miller HI; Young FE Science; 1987 Jan; 235(4784):14. PubMed ID: 3798092 [No Abstract] [Full Text] [Related]
25. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting, February 2, 1987. Recomb DNA Tech Bull; 1987 Dec; 10(4):125-57. PubMed ID: 3481096 [No Abstract] [Full Text] [Related]
27. Models of genetically engineered organisms and their ecological impact. Regal PJ Recomb DNA Tech Bull; 1987 Sep; 10(3):67-85. PubMed ID: 3317526 [No Abstract] [Full Text] [Related]
28. Clear-cut biotechnology regulations are a must. Jefferson EG Med Mark Media; 1985 Jul; 20(7):28-9, 32-3. PubMed ID: 10272849 [No Abstract] [Full Text] [Related]
30. Summary of in-house EPA workshop to define research/technical support approaches in biotechnology. Fowle JR Recomb DNA Tech Bull; 1984 Jun; 7(2):65-7. PubMed ID: 6473824 [TBL] [Abstract][Full Text] [Related]
31. Recombinant DNA research; proposed actions under guidelines. National Institutes of Health. Recomb DNA Tech Bull; 1987 Sep; 10(3):90-104. PubMed ID: 3685453 [TBL] [Abstract][Full Text] [Related]
32. The regulation of biotechnology products as "toxics". Shanks PL; Gibbons SL Healthspan; 1985 Feb; 2(2):21-8. PubMed ID: 10289625 [No Abstract] [Full Text] [Related]
33. Testimony of the American Society for Medical Technology before the Center for Disease Control's Public Hearing on proposed personnel standards. Price GD Am J Med Technol; 1980 Aug; 46(8):597-602. PubMed ID: 6252778 [No Abstract] [Full Text] [Related]
34. Administration hints at clampdown on biotechnology exports. Budiansky S; David P Nature; 1984 May 31-Jun 6; 309(5967):389. PubMed ID: 6587188 [No Abstract] [Full Text] [Related]
35. The attitudes of religious, environmental, and science policy leaders toward biotechnology. Miller JD Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277 [TBL] [Abstract][Full Text] [Related]
36. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production. Karny GM Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588 [No Abstract] [Full Text] [Related]
39. Global trends in plant transgenic science and technology (1973-2003). Vain P Trends Biotechnol; 2006 May; 24(5):206-11. PubMed ID: 16569453 [TBL] [Abstract][Full Text] [Related]